Like pharma sector, prefer Lupin: Jeff Chowdhry

Jeff Chowdhry, senior EM Fund Manager at LGM told CNBC-TV18, "We are shareholders in Lupin but we are not shareholders in Sun Pharmaceutical Industries. I think it is fair to say that both companies are pretty well managed. We marginally prefer Lupin because we think that the pipeline is better and we also think that it has got more growth opportunities than Sun Pharma but Sun Pharma is a good company as well." "We also own shares in Glenmark Pharma which has done very well. It is a pretty well run company with good opportunities," he said. "I like the pharmaceutical sector. We own Lupin and Glenmark and these in my opinion are just temporary setbacks on the journey."